Navigation Links
Calithera Biosciences Presents Data for CB-839 in Triple-Negative Breast Cancer Models at the 2013 San Antonio Breast Cancer Symposium
Date:12/12/2013

rogen receptor positive.  In vitro treatment with CB-839 reduced cell viability and induced apoptosis in the majority of triple negative breast cancer cell lines.  CB-839 treatment also resulted in significant anti-tumor activity in two triple-negative breast cancer xenograft models: as a single agent in a patient-derived tumor with a metabolite and expression profile suggestive of high glutamine utilization, and in a second cell line model in which CB-839 demonstrated robust anti-cancer activity both as a single agent and in combination with paclitaxel.

To verify biomarker indicators for CB-839 sensitivity, Calithera researchers studied the Cancer Genome Atlas mRNA expression dataset (n=756) of primary human breast cancers and confirmed a pattern of significantly increased markers of glutaminase in triple-negative breast cancers relative to hormone-receptor driven tumors.  Similar observations were made at the metabolite level in 262 primary breast tumors, suggesting that biomarkers of glutamine utilization and high glutaminase expression may be useful in identifying patients most likely to benefit from CB-839.

Calithera presented these data today during the Tumor Cell and Molecular Biology session in a poster titled:  Antitumor Activity of the Glutaminase Inhibitor, CB-839, in Triple-Negative Breast Cancer (# P2-09-03).

About Calithera Biosciences
Calithera is discovering and developing novel small molecule oncology therapeutics that inhibit pathways critical to tumor growth and survival.  The Calithera team has the experience and the ability needed to discover novel therapeutics and advance these discoveries through clinical development.  The company is applying this expertise to build a pipeline of anti-cancer compounds that are distinct from other oncology therapeutics.  Calithera's lead clinical candidate, CB-839, blocks glutaminase, an enzyme critical to tumor metabolism, and is poised
'/>"/>

SOURCE Calithera Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Calithera Biosciences Secures $35 Million in Series D Financing
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
7. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
8. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
9. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
10. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
11. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... 29, 2015 The Parenteral Drug Association is ... Board of Professional Engineers and Land Surveyors ... to professional engineers for continuing professional competency (CPC) credits. ... value and quality of PDA,s professional education offerings," said ... and hands-on professional training at the Training and Research ...
(Date:6/29/2015)... EASTON, Mass. , June 29, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale ... preparation solutions to the worldwide life sciences industry, ... the Institute of Molecular Systems Biology, ETH Zurich, ... proteomic profiling and classification of prostate cancer tissue ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Feb. 21, 2012 A collaboration between NineSigma and ... advance HIV vaccine research by identifying new approaches to ... provider of innovation services , NineSigma has connected ... and helped it identify two scientists who will receive ...
... #8116 -- Precyse, a leader in health information ... HIMSS 2012 Annual Conference and Exposition that the ... improvements in revenue cycle workflow, coding accuracy, and ... adopting Precyse,s integrated health information management (HIM) and ...
Cached Medicine Technology:IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 3IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 4Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 2Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 3Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 4
(Date:6/30/2015)... , ... June 30, 2015 , ... Scott Purdy, the ... name to Provider XO. Scott Purdy stated that the XO stands for eXtra Operability ... that automate the workflow processes of the Revenue Cycle. , Provider XO, based ...
(Date:6/29/2015)... FL (PRWEB) , ... June 30, 2015 , ... Sublime ... special 50% Off offer. The oil, ideal for natural skincare and even culinary ... and easy way is something most people desire, and Oil Pulling can accomplish this. ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down ... at Soldier Field over the 4th of July weekend. Concertgoers can add promo/coupon ... have only recently caught on to their innovative sound, will not want to miss ...
(Date:6/29/2015)... ... June 29, 2015 , ... An upcoming documentary for ... James Earl Jones will offer a fresh perspective on conflict in sports with ... is one of several thought leaders from around the sports industry that will discuss ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... group series as part of its support program. This discussion series is part ... and other support services to those affected by mesothelioma. , The six week ...
Breaking Medicine News(10 mins):Health News:Dephinitive Systems Is Getting a New Name 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 2Health News:Dr. Marc Williams Joins SCI and In America Sports Documentary 3Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3
... caused by injury to the peripheral nerves in diseases ... motion disorders and trauma, and does not respond well ... rodents by scientists from the University of California, San ... a protein called LRP1 may help to ease neuropathic ...
... CARROLLTON, Texas, Dec. 5 Fry Construction, ... facilities, has,been recently featured as a success "case ... The feature, entitled "Specialization Leads,to Success," is an ... the,story behind its incomparable success in the industry., ...
... Inc., a leader in,applying integrated human biology systems ... entered into a collaboration agreement with,UCB, a global ... will apply its BioMAP(R) Systems to evaluate a,number ... support of target,differentiation, lead development, and drug candidate ...
... Nexia Holdings, Inc.,(OTC Bulletin Board: NEXA), a diversified ... and real estate, issued the following,update to shareholders from ... I am pleased to address shareholder concerns about the ... I anticipate a 1-for-100 split to be effective ...
... New Guide on http://www.thepill.com , RARITAN, N.J., Dec. ... how much do Modern Girls really know about this birth,control ... http://www.prnewswire.com/mnr/ortho/29291/ , Since its development more than ... used birth control method. Although more than 80 percent,of American ...
... - People who believe,in themselves can raise their aspirations, ... things by watching others do them., So says ... psychology who has won the 2008 University of Louisville,Grawemeyer ... Grawemeyer,psychology prize from among 31 nominations from five countries., ...
Cached Medicine News:Health News:Protein found that may provide relief from neuropathic pain 2Health News:Fry Construction Is Featured in Key Industry Publication 2Health News:BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB 2Health News:Nexia Holdings CEO Issues Update to Shareholders 2Health News:Nexia Holdings CEO Issues Update to Shareholders 3Health News:Nexia Holdings CEO Issues Update to Shareholders 4Health News:Video: What 'Modern Girls' Should Know About the Pill 2Health News:Video: What 'Modern Girls' Should Know About the Pill 3Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2
The 16 liter Laparoscopy Insufflator combines high safety and precise pressure control with simple operation....
The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
... GenoID's kit is the first commercially ... for clinical diagnostic use. , ,The ... and 5 low-risk genotypes of HPV ... PCR technology but simplifying the process ...
... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ...
Medicine Products: